Press Releases

Archive: November 2021


Phase III demyelinating disorder contract award with largest Pharma client worth >£1.0m

IXICO plc, the AI data analytics company delivering insights in neuroscience, announces that it has been selected by its largest pharma client to provide neuroimaging services for a new Phase III clinical trial focused on a demyelinating disorder.

Read more